`
`Equivalent of Form PTO/SB/08a/b (07-09)
`Complete if Known
`
`Filing Date
`March 13, 2023
`First Named Inventor
`Dennis Mark MCDAID
`Art Unit
`To Be Assigned
`Examiner Name
`To Be Assigned
`Attorney Docket Number|4384.0010005
`
`
`
`INFORMATION DISCLOSURE
`STATEMENTBY APPLICANT
`(Use as many sheets as necessary)
`
`
`
`
`
`
`
`
`U.S. PATENT DOCUMENTS
`pies. conumns, Lanes, Where
`Publication Date
`Document Number
`Cite
`Examiner
`NameofPatentee or
`
`
`
`
`initials* 2(fknown)|MM-DD-YYYYNo! ; Applicant of Cited Document elevantPassages or Relevant
`
`im
`0.
`Number-Kind Code
`Figures Appear
`
`||USI PHILLIPS;Jeffrey Owen
`
`||use LOS; Mario Atilio
`
`
`US3_|US-9051100-B2 06-09-2015|SUZUKI; Yoshihiro
`
`|| uss KUMAR:Ashish etal.
`
`
`||US6 MITTAL;Bhupesh Kumaretal.
`
`||us7 PROEHL;Gerald T. etal.
`
`||uss TANEIJA; Rajneesh etal.
`
`US9_|US-20140271853-Al__| 09-18-2014|HALL: Warrenetal.
`
`||Us HEPBURN:Bonnie et al.
`
`
`||usi2 SUTHERLAND:D.C., et al.
`
`|«| US13_|US-11207307-B2 12-28-2021|FALLIN;Kenetal.
`|__| uS14|US-20050220870-A1|10-06-2005_|HEPBURN;Bonnieetal.
`
`US15|US-20050098526-A1 05-12-2005 CATALIN;Robertino
`
`
`FOREIGN PATENT DOCUMENTS
`
`Foreign Patent Document
`Publication
`5
`Cite
`Nameof Patentee or
`Date
`3
`a
`Examiner
`:
`.
`_
`_
`1
`Ce
`aon
`Applicant of Cited Document
`MM.DD-YYVY
`Country Code Number
`No.
`initials
`(if known)
`Kind Code’
`
`ES-2283172-Al 10-16-2007|UNIV GRANADA[ES]
`
`GB-2189698-A 11-04-1987|HAESSLE AB [SE]
` FP3_|WO-200151050-Al|07-19-2001|UNIV MISSOURI[US]
`
`FP4|WO-2008016887-A2_| 02-07-2008|GRACEWAY PHARMALLC [US]
`WO-2013139377-Al_| 09-26-2013|BAGO SA LABOR[AR]et al.
`
`WO-2017218894-Al|12-21-2017|CUTISPHARMAINC[US]
`EP-1905426-Bl 09-05-2012|BAGO SA LABOR[AR]
`
`
`FP8|EP-2201952-Al 06-30-2010|UNIV MISSOURI[US]
`
`Pages, Columns, Lines,
`‘Where Relevant Passages or
`Relevant Figures Appear
`
`Examiner Signature| ate Considered |
`
`*EXAMINER:Initial if reference considered, whether ornot citation is in conformance with MPEP 609. Draw line throughcitation if not in conformance and
`not considered. Include copy of this form with next communication to applicant. | Applicant’s unique citation designation number(optional). ? See Kinds
`Codes of USPTO Patent Documents at www.uspto.gov or MPEP 901.04. 3 Enter Office that issued the document, by the two-letter code (WIPO Standard
`ST.3). 4 For Japanese patent documents, the indication of the yearof the reign of the Emperor must precede the serial number of the patent document. ° Kind
`of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. ° Applicant is to place a check mark here if
`English language Translationis attached.
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/S.R.H/
`
`
`
`Substitute for form 1449/PTO
`
`Equivalent of Form PTO/SB/08a/b (07-09)
`Complete if Known
`
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`
`Art Unit
`(Use as many sheets as necessary)
`To Be Assigned
`
`Examiner Name
`To Be Assigned
`Attorney Docket Number|4384.0010005
`
`March 13, 2023
`
`Filing Date
`
`Publishing, United Arab Emirates (2018).
`Dis. Child. 61(2):159-163, BMJ, United Kingdom (1986).
`
`NON PATENT LITERATURE DOCUMENTS
`
`Examiner
`Initials*
`
`Cite No.!
`
`Include name of the author (in CAPITAL LETTERS),title of the article (when appropriate), title of the item (book,
`magazine, journal, serial, symposium,catalog,etc.), date, page(s), volume-issue number(s), publisher, city and/or country
`where published
`
`International Search Report and Written Opinion for International Application No.
`PCT/IB2020/059280, European Patent Office, Netherlands, mailed on January 19, 2021, 18 pages
`
`EPO machinetranslation of ES 2281172 Al (document FP1), European Patent Office,
`Netherlands, January 13, 2021, 12 pages.
`
`ALLISON,M.E.and Walker, V., “The sodium and potassium intake of 3 to 5 year olds,” Arch.
`
`DETTMAR,P.W., et al., “Administration of an alginate based gastric reflux suppressant on the
`bioavailability of omeprazole,” GI Café 7(2): page 1, Square Pharmaceuticals Ltd., Bangladesh
`(2014) (total 4 pages).
`
`HIGUERA-DE-LA-TIJERA,F., “Efficacy of omeprazole/sodium bicarbonate treatment in
`gastroesophagealreflux disease: a systematic review,” MedWave 18(1):e7179, Medwave
`Estudios Limitada, Chile (2018) (7 pages).
`
`LEIMAN,D.A., et al., “Alginate therapy is effective treatment for GERD symptoms: a systematic
`review and meta-analysis,” Dis. Esophag. 30(5):1-9, Oxford Academic Press, United Kingdom
`(2017).
`
`MANABE,N., et al., “Efficacy of adding sodium alginate to omeprazole in patients with
`nonerosive reflux disease: a randomizedclinical trial,” Dis. Esophag. 25(5):373-380, Oxford
`Academic Press, United Kingdom (2011).
`
`OLIVIERA,A.C., et al., “Potassium urinary excretion and dietary intake: a cross-sectional
`analysis in 8-10 year-old children,” BMC Pediatrics 15:60, BioMed Central, United Kingdom
`(2015) (10 pages).
`
`RANVIRSINGH,T.A., et al., “Formulation and Evaluation of Floating Alginate Beads on Anti
`Ulcer Drug,” Int. J. Pharm. Sci. Rev. Res. 21(2):120-124, Global Research Online, India (2013).
`
`SAIED, N., et al., “Assessment of Sodium and Potassium Intakes in Children Aged 6 to 18 Years
`by 24h Urinary Excretion in City of Rabat, Morocco,” J. Nutr. Metab. 2018:8687192, Hindawi
`
`Examiner Signature| ate Considered |
`
`*EXAMINER:Initial if reference considered, whether ornot citation is in conformance with MPEP 609. Draw line throughcitation if not in conformance and
`not considered. Include copy of this form with next communication to applicant. | Applicant’s unique citation designation number(optional). ? See Kinds
`Codes of USPTO Patent Documents at www.uspto.gov or MPEP 901.04. 3 Enter Office that issued the document, by the two-letter code (WIPO Standard
`ST.3). 4 For Japanese patent documents, the indication of the yearof the reign of the Emperor must precede the serial number of the patent document. ° Kind
`of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. ° Applicant is to place a check mark here if
`English language Translationis attached.
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/S.R.H/
`
`
`
`Substitute for form 1449/PTO
`
`Equivalent of Form PTO/SB/08a/b (07-09)
`Complete if Known
`
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`
`Art Unit
`(Use as many sheets as necessary)
`To Be Assigned
`
`Examiner Name
`To Be Assigned
`Attorney Docket Number|4384.0010005
`
`March 13, 2023
`
`Filing Date
`
`2020.
`
`
`Include name of the author (in CAPITAL LETTERS),title of the article (when appropriate), title of the item (book,
`Examiner
`Initials*
`Cite No.!|magazine, journal, serial, symposium,catalog, etc.), date, page(s), volume-issue number(s), publisher, city and/or country
`where published
`
`NON PATENT LITERATURE DOCUMENTS
`
`TIAN, N., et al., “Sodium and potassium intakes among USinfants and preschool children, 2003-
`2010,” Am. J. Clin. Nutr. 98:1113-1122, American Society for Nutrition, United States (2013).
`
`Highlights of Prescribing Information for “KONVOMEP™(omeprazole and sodium bicarbonate
`for oral suspension)”, initial U.S. Approval 2004, the U.S. Food and Drug Administration, United
`States, revised August 2022.
`
`DELLAGRECA,M.., et al., “Degradation of lansoprazole and omeprazole in the aquatic
`environment,” Chemosphere 63:1087-1093, Elsevier, Netherlands (2006).
`
`Non-Final Office Action, mailed April 28, 2022, in U.S. Application No. 17/061,630,filed
`October 2, 2020.
`
`Notice of Allowance mailed December14, 2022, in U.S. Application No. 17/061,630,filed
`October 2, 2020.
`
`Notice of Allowance mailed July 7, 2023, in U.S. Application No. 17/061,630,filed October2,
`
`Examiner Signature
`
`Date Considered
`
`12/14/2024
`
`*EXAMINER:Initial if reference considered, whether ornot citation is in conformance with MPEP 609. Draw line throughcitation if not in conformance and
`not considered. Include copy of this form with next communication to applicant. | Applicant’s unique citation designation number(optional). ? See Kinds
`Codes of USPTO Patent Documents at www.uspto.gov or MPEP 901.04. 3 Enter Office that issued the document, by the two-letter code (WIPO Standard
`ST.3). 4 For Japanese patent documents, the indication of the yearof the reign of the Emperor must precede the serial number of the patent document. ° Kind
`of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. ° Applicant is to place a check mark here if
`English language Translationis attached.
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/S.R.H/
`
`

Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ ChargeStill Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.

This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.

One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site